Inactive Instrument
Kadimastem Stock OTC Markets
Stocks
KMSTF
IL0011284614
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 55.03M 17.96M 16.04M 14.92M 13.58M 25.63M 1.74B 25.74M 180M 70.38M 886M 67.46M 65.98M 2.84B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 55.03M 17.96M 16.04M 14.92M 13.58M 25.63M 1.74B 25.74M 180M 70.38M 886M 67.46M 65.98M 2.84B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
34.42% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -0.78% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.78% | +153.00% | - | - | 17.96M | |
| -2.59% | -5.70% | +40.86% | +83.11% | 72.13B | |
| +3.23% | -13.45% | +6.00% | +55.77% | 49.41B | |
| +1.56% | +2.07% | +5.03% | +33.38% | 47.24B | |
| +0.87% | -7.83% | +296.82% | +657.83% | 40.32B | |
| +0.39% | -0.32% | +29.55% | +30.83% | 42.61B | |
| +1.24% | -1.20% | +0.96% | +103.86% | 39.81B | |
| -2.13% | -2.18% | +7.51% | +50.31% | 30.52B | |
| +5.32% | +0.11% | -8.77% | -12.81% | 23.13B | |
| +3.78% | +5.71% | +16.43% | -1.77% | 21.09B | |
| Average | +1.06% | -3.91% | +43.82% | +111.17% | 40.7B | |
| Weighted average by Cap. | +0.74% | -4.28% | +46.74% | +118.77% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
11
